These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 16415928)

  • 21. Acute CNS infection is insufficient to mediate chronic T cell retention.
    Marten NW; Hohman M; Stohlman SA; Atkinson RD; Hinton DR; Bergmann CC
    Adv Exp Med Biol; 2001; 494():349-54. PubMed ID: 11774491
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.
    Chua MM; MacNamara KC; San Mateo L; Shen H; Weiss SR
    J Virol; 2004 Feb; 78(3):1150-9. PubMed ID: 14722270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse hepatitis virus infection of the CNS: a model for defense, disease, and repair.
    Schaumburg CS; Held KS; Lane TE
    Front Biosci; 2008 May; 13():4393-406. PubMed ID: 18508518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8 T cell mediated immunity to neurotropic MHV infection.
    Bergmann CC; Marten NW; Hinton DR; Parra B; Stohlman SA
    Adv Exp Med Biol; 2001; 494():299-308. PubMed ID: 11774484
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccine-induced memory CD8+ T cells cannot prevent central nervous system virus reactivation.
    Ramakrishna C; Atkinson RA; Stohlman SA; Bergmann CC
    J Immunol; 2006 Mar; 176(5):3062-9. PubMed ID: 16493065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fine Tuning the Cytokine Storm by IFN and IL-10 Following Neurotropic Coronavirus Encephalomyelitis.
    Savarin C; Bergmann CC
    Front Immunol; 2018; 9():3022. PubMed ID: 30619363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection.
    Bergmann CC; Ramakrishna C; Kornacki M; Stohlman SA
    J Immunol; 2001 Aug; 167(3):1575-83. PubMed ID: 11466379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.
    Atkinson JR; Bergmann CC
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells.
    Trifilo MJ; Montalto-Morrison C; Stiles LN; Hurst KR; Hardison JL; Manning JE; Masters PS; Lane TE
    J Virol; 2004 Jan; 78(2):585-94. PubMed ID: 14694090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody prevents virus reactivation within the central nervous system.
    Lin MT; Hinton DR; Marten NW; Bergmann CC; Stohlman SA
    J Immunol; 1999 Jun; 162(12):7358-68. PubMed ID: 10358187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system.
    Hickey MJ; Held KS; Baum E; Gao JL; Murphy PM; Lane TE
    Viral Immunol; 2007 Dec; 20(4):599-608. PubMed ID: 18158733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system.
    Marten NW; Stohlman SA; Smith-Begolka W; Miller SD; Dimacali E; Yao Q; Stohl S; Goverman J; Bergmann CC
    J Immunol; 1999 Apr; 162(7):3905-14. PubMed ID: 10201909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection.
    Cervantes-Barragán L; Firner S; Bechmann I; Waisman A; Lahl K; Sparwasser T; Thiel V; Ludewig B
    J Immunol; 2012 Apr; 188(8):3678-85. PubMed ID: 22407917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-magnitude, virus-specific CD4 T-cell response in the central nervous system of coronavirus-infected mice.
    Haring JS; Pewe LL; Perlman S
    J Virol; 2001 Mar; 75(6):3043-7. PubMed ID: 11222733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenesis of murine coronavirus infection of the central nervous system.
    Lane TE; Hosking MP
    Crit Rev Immunol; 2010; 30(2):119-30. PubMed ID: 20370625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine expression and viral infection of the central nervous system: regulation of host defense and neuropathology.
    Liu MT; Lane TE
    Immunol Res; 2001; 24(2):111-9. PubMed ID: 11594450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both spike and background genes contribute to murine coronavirus neurovirulence.
    Iacono KT; Kazi L; Weiss SR
    J Virol; 2006 Jul; 80(14):6834-43. PubMed ID: 16809289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis.
    Muse M; Kane JA; Carr DJ; Farber JM; Lane TE
    Virology; 2008 Dec; 382(2):132-44. PubMed ID: 18973912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the mouse hepatitis virus receptor by central nervous system microglia.
    Ramakrishna C; Bergmann CC; Holmes KV; Stohlman SA
    J Virol; 2004 Jul; 78(14):7828-32. PubMed ID: 15220458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection.
    Stiles LN; Hardison JL; Schaumburg CS; Whitman LM; Lane TE
    J Immunol; 2006 Dec; 177(12):8372-80. PubMed ID: 17142734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.